Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data

Article ID	Journal	Published Year	Pages	File Type
5647453	The Journal of Allergy and Clinical Immunology: In Practice	2016	9 Pages	PDF

Abstract

The findings from this large, international patient registry documented widespread implementation of pnfC1-INH self-administration outside of a health care setting consistent with current HAE guidelines. These real-world data revealed pnfC1-INH usage for a variety of reasons in patientsÂ with HAE and showed a high level of safety regardlessÂ ofÂ administration setting or reason for use.

Keywords

SMQ TEES C1-INH SAEs TIA C1 inhibitor Hereditary angioedema European Union Safety on demand Deep vein thrombosis DVT HAE transient ischemic attack thromboembolic events self-administration Real-world Dosing Medical Dictionary for Regulatory Activities Patient registry thromboembolic event Prophylaxis adverse event serious adverse events HIV human immunodeficiency virus